The Human Biome · Article 15 of 26
The Mycobiome: The Fungal Side of the Human Microbiome
Educational and scope notice
This material is for education only and does not provide medical diagnosis or treatment advice. IEMT practitioners should remain within their professional scope and refer clients to an appropriately qualified healthcare professional where medical assessment, treatment, prescribed medication, supplements or restrictive diets are involved.
While most discussions of the human microbiome focus on bacteria, a lesser-known yet equally important component is the mycobiome, the collection of fungal species that coexist with us in and on the body. Although fungi represent a much smaller fraction of the total microbial population, they play vital roles in digestion, immunity, and maintaining microbial balance. When disrupted, they can also contribute to inflammation and disease.
Understanding the Mycobiome
The term 'mycobiome' refers to the fungal counterpart of the microbiome. Fungi inhabit nearly all mucosal surfaces, including the skin, mouth, respiratory tract, gut, and reproductive organs. In healthy individuals, these organisms live in symbiosis with bacteria, influencing each other’s growth and immune recognition.
Unlike bacteria, fungi are eukaryotic; they possess nuclei, organelles, and complex cell walls. This makes them evolutionarily closer to human cells than bacteria are, and it also complicates antifungal therapy because drug targets must distinguish between fungal and human structures.
Major Fungal Genera in the Human Body
Research using DNA sequencing has identified over 150 fungal genera associated with the human body. The most common include:
- Candida – the most abundant genus in the human mycobiome; found in the gut, mouth, and vaginal tract. Candida albicans is a normal commensal but can become pathogenic under certain conditions.
- Malassezia – dominant on the skin and scalp; involved in conditions such as dandruff and seborrhoeic dermatitis when overgrown.
- Aspergillus – commonly inhaled from the environment; usually harmless but may cause respiratory infections in immunocompromised individuals.
- Cladosporium and Penicillium – environmental fungi frequently detected in nasal passages and lungs.
- Saccharomyces – yeast species present in the gut and diet (notably from fermented foods); often beneficial and used in probiotic supplements.
Cross-Kingdom Interactions—How Bacteria and Fungi Communicate
The human microbiome is not neatly divided into bacterial and fungal worlds; it is an interactive ecosystem in which communication between species shapes health and disease. These bacterial–fungal relationships, often called “cross-kingdom interactions,” occur through shared metabolic pathways, chemical signalling, and physical biofilms.
In a balanced state, bacteria and fungi coexist in mutual regulation. Beneficial bacteria, such as Lactobacillus and Bifidobacterium species, produce organic acids (lactic and acetic acids) that inhibit fungal overgrowth, while fungi, such as Saccharomyces boulardii, can restrain pathogenic bacteria by producing antimicrobial peptides and stimulating immune responses. Together, they create ecological stability within the gut and on mucosal surfaces.
When this relationship is disturbed (for instance, after antibiotic use, excessive sugar intake, or immune suppression), cooperation can turn to competition. Some fungi, Candida albicans, form biofilms with bacteria such as Escherichia coli and Klebsiella pneumoniae, creating mixed microbial communities that resist immune clearance and antibiotic treatment. These biofilms amplify inflammation and are now recognised as contributors to chronic gut and sinus disorders.
Cross-kingdom communication also occurs via molecular messengers. Bacteria release short-chain fatty acids, quorum-sensing molecules, and hydrogen peroxide that influence fungal growth and morphology, while fungi secrete alcohols and oxylipins that alter bacterial gene expression. The balance of these signals determines whether the relationship remains symbiotic or shifts toward pathogenic cooperation.
Understanding these interactions helps explain why bacterial dysbiosis often leads to secondary fungal imbalance: and why restoring bacterial diversity can indirectly rebalance the fungal community. Effective microbiome therapy, therefore, addresses the entire ecosystem, rather than targeting one kingdom in isolation.
In essence, bacterial and fungal populations are ecological partners in health and conspirators in disease. Maintaining diversity, stable pH, and immune tolerance allows both kingdoms to coexist in a state of dynamic equilibrium that supports the host rather than harms it.
Factors That Disrupt the Mycobiome
The fungal component of the human microbiome is sensitive to environmental, dietary, and medical influences. The following table outlines common factors that disturb the fungal–bacterial balance and practical strategies to maintain stability.
| Disruptive Factor | Mechanism / Biological Effect | Preventive or Restorative Strategy |
|---|---|---|
| Broad-Spectrum Antibiotics | Reduce bacterial competitors, allowing fungal species such as Candida to proliferate unchecked. | Use antibiotics only when necessary. Follow with probiotic or prebiotic support. Consider Saccharomyces boulardii supplementation during treatment. |
| High-Sugar and Refined-Carbohydrate Diet | Provides energy substrates for yeast fermentation and promotes Candida overgrowth in the gut and mouth. | Limit refined sugars Increase fibre, polyphenols, and complex carbohydrates to support bacterial competitors. |
| Chronic Stress | Elevated cortisol and immune suppression reduce host defence, favouring fungal persistence and biofilm formation. | Support stress regulation through sleep hygiene, relaxation practices, and adequate nutrition. Maintain a regular circadian rhythm. |
| Immunosuppressive Conditions or Medications | Weakens antifungal immune responses (especially Th17 and neutrophil function), increasing risk of systemic infection. | Monitor fungal biomarkers in at-risk individuals. Use targeted antifungal prophylaxis under medical guidance. |
| Hormonal Changes | Fluctuations in oestrogen and progesterone influence vaginal and gut fungal balance, promoting Candida growth during certain phases. | Support hormonal stability through a balanced diet, liver health, and reducing unnecessary hormone-disrupting substances. |
| Prolonged Use of Antifungal Drugs | Can select for resistant fungal strains and reduce beneficial commensal species, leading to recurrent imbalance. | Reserve antifungal use for confirmed infections. Pair with microbiome restoration strategies. |
| Environmental Mould Exposure | Chronic inhalation of spores (e.g., Aspergillus, Cladosporium) challenges immune balance and may alter respiratory mycobiota. | Improve ventilation and reduce indoor humidity. Monitor damp areas. Consider HEPA filtration in mould-prone environments. |
| Low Microbial Diversity | Reduced bacterial variety limits cross-kingdom competition, allowing fungi to dominate. | Encourage a diverse diet rich in fibre and fermented foods. Minimise ultra-processed products. |
| Long-Term PPI (Proton Pump Inhibitor) Use | Reduced stomach acidity alters upper GI microbiota, promoting fungal colonisation. | Use PPIs only as clinically required. Taper with medical guidance. Support digestion naturally where possible. |
Summary: The mycobiome thrives in harmony with bacterial and immune systems. Its disruption often reflects broader lifestyle, dietary, or pharmaceutical influences. Prevention focuses on microbial diversity, balanced nutrition, and maintaining a resilient immune system.
Candida and the Gut Mycobiome
Candida albicans is normally kept in check by the bacterial microbiome and host immune defences. When bacterial balance is disrupted (for example, after antibiotic use, high-sugar diets, or chronic stress), Candida can overgrow, leading to a condition commonly referred to as intestinal candidiasis or fungal dysbiosis.
Overgrowth may manifest as bloating, fatigue, oral thrush, sugar cravings, or increased sensitivity to foods and chemicals. While “candida overgrowth” has been overused in popular health media, spawning an entire industry in dubious treatments, genuine fungal imbalance is well documented in certain contexts, especially among those with compromised immunity or disrupted gut flora.
Experimental models show that fungal dysbiosis can amplify intestinal inflammation by stimulating immune cells (particularly the Th17 and IL-17 pathways) and by synergistically interacting with pathogenic bacteria such as Escherichia coli and Klebsiella. This cross-kingdom communication contributes to chronic gut inflammation.
Common Commensal and Opportunistic Fungi
This table summarises key fungal species that form part of the human mycobiome, their usual habitats, and their contrasting roles in balance versus overgrowth.
| Fungal Species | Primary Location | Balanced State | Overgrowth/Dysbiosis Effects |
|---|---|---|---|
| Candida albicans | Gut Mouth Vagina Skin | Normal commensal yeast aiding digestion and mucosal immunity. | Causes oral thrush, vaginal candidiasis, gut inflammation, and fatigue when overgrown. |
| Candida glabrata | Vaginal and urinary tracts | Low-level resident species within mucosal flora. | Can become antifungal-resistant; linked to recurrent urinary and genital infections. |
| Malassezia globosa & M. restricta | Scalp and oily skin regions | Break down skin lipids, maintaining microbiome diversity. | Overgrowth causes dandruff, seborrhoeic dermatitis, and itchiness. |
| Aspergillus fumigatus | Respiratory tract | Common airborne mould spores are usually cleared by a healthy immune system. | May cause allergic bronchopulmonary aspergillosis or invasive infection in immunocompromised individuals. |
| Cladosporium spp. | Nasal passages Sinuses Lungs | Environmental exposure with no ill effect in most people. | Can trigger allergic rhinitis, asthma, or chronic sinus irritation. |
| Saccharomyces boulardii | Gut (dietary and probiotic yeast) | Beneficial probiotic Supports gut barrier and competes with pathogens. | Very rarely causes bloodstream infection in severely immunocompromised hosts. |
| Penicillium spp. | Respiratory tract Environment | Common mould. Usually harmless exposure. | May provoke allergic or hypersensitivity responses in sensitive individuals. |
| Cryptococcus neoformans | Environment Respiratory tract | Environmental yeast. Generally non-pathogenic in healthy people. | Can cause meningitis in those with HIV/AIDS or weakened immunity. |
Note: Fungal balance depends on bacterial competition, immune regulation, and dietary environment. Broad-spectrum antibiotics, excess sugar, and immune suppression are common triggers for fungal dysbiosis.
The Mycobiome Beyond the Gut
- Oral Mycobiome: The mouth harbours several fungal species, with Candida albicans again the most common. Oral candidiasis (“thrush”) arises when immune defences are weakened or the bacterial flora is disturbed, often by antibiotics or corticosteroids.
- Skin Mycobiome: Dominated by Malassezia species, which metabolise skin lipids. While beneficial in small numbers, they can trigger dandruff, eczema, or seborrhoeic dermatitis when overgrown.
- Respiratory Tract: Fungi such as Aspergillus fumigatus and Cladosporium are commonly inhaled; in susceptible individuals, they may provoke allergic bronchopulmonary aspergillosis or chronic sinusitis.
- Vaginal Mycobiome: Dominated by Candida albicans and Candida glabrata. Overgrowth can cause vulvovaginal candidiasis, particularly following antibiotic use or hormonal fluctuation.
Immune Regulation and Fungal Tolerance
The immune system recognises fungi through specialised receptors, including Dectin-1 and Toll-like receptors (TLRs), which distinguish fungal cell wall components such as β-glucans and mannans. A balanced immune response promotes tolerance to commensal fungi while preventing invasion. Excessive immune activation, however, can lead to chronic inflammation or autoimmune-like responses, as seen in inflammatory bowel disease (IBD), where antibodies to Saccharomyces cerevisiae (ASCA) are frequently detected.
Interplay Between Bacteria and Fungi
The bacterial and fungal components of the microbiome interact continuously. Beneficial bacteria such as Lactobacillus rhamnosus and Bifidobacterium longum help suppress fungal overgrowth by producing organic acids and competing for adhesion sites. Conversely, some fungi produce biofilms that shield harmful bacteria from antibiotics and immune attack. This cross-kingdom synergy is now a major focus in microbiome research.
Clinical and Therapeutic Perspectives
- Antifungal medications (e.g., fluconazole, nystatin) may be required for clinically significant fungal infections but should be used judiciously to avoid microbiome disruption.
- Dietary strategies focusing on reduced refined sugar intake and inclusion of prebiotic fibres (inulin, resistant starch) help support bacterial competitors that regulate fungi.
- Probiotic and postbiotic interventions are under study; certain strains, including Lactobacillus plantarum and Saccharomyces boulardii, show promise in restoring fungal balance and reducing gastrointestinal symptoms.
- Environmental and immune factors (humidity, antibiotics, stress hormones) also influence fungal composition and should be considered in management.
Restoring the Mycobiome
Rebalancing the mycobiome requires restoring harmony between fungi, bacteria, and the immune system. Because fungal imbalance often follows antibiotic use, poor diet, or chronic stress, effective recovery focuses on microbial diversity and immune regulation rather than simply eradicating fungi.
Dietary Regulation
Reduces substrates for yeast fermentation and supports bacterial competitors.
• Limit refined sugars, alcohol, and processed carbohydrates.
• Emphasise vegetables, whole grains, legumes, and polyphenol-rich foods.
• Incorporate naturally fermented foods (e.g., sauerkraut, kefir, miso) if tolerated.
Probiotics and Beneficial Yeasts
Reintroduces competitive microbes that inhibit fungal overgrowth.
• Use Saccharomyces boulardii to suppress Candida adhesion and toxin release.
• Combine with Lactobacillus and Bifidobacterium strains for synergistic bacterial–fungal balance.
• Rotate probiotic strains periodically to enhance diversity.
Prebiotic Support
Feeds beneficial bacteria that indirectly restrain fungal growth.
• Include soluble fibres such as inulin, pectin, and resistant starch.
• Use foods like oats, onions, garlic, chicory, and green bananas.
• Introduce gradually to prevent bloating or irritation.
Immune Modulation
Balances antifungal immune pathways (Th17, IL-17) and reduces inflammation.
• Maintain adequate vitamin D, zinc, and selenium levels.
• Manage chronic stress and sleep deprivation.
• Avoid unnecessary corticosteroid or immunosuppressive use.
Environmental Hygiene
Prevents reinoculation or overexposure to environmental spores.
• Reduce indoor dampness and clean visible mould.
• Improve ventilation and air filtration in humid environments.
• Replace contaminated humidifiers, shower seals, or air-conditioning filters.
Restorative Lifestyle
Supports natural microbial equilibrium through systemic resilience.
• Prioritise restorative sleep and circadian stability.
• Engage in moderate physical activity to enhance gut motility and immune tone.
• Avoid unnecessary use of antiseptics, mouthwashes, or antifungal soaps.
Restoring the mycobiome is less about elimination and more about ecology - creating the right conditions for balance, competition, and cooperation among microbial species.
Future Directions
The human mycobiome is an emerging field. Metagenomic sequencing continues to uncover new fungal species and their roles in health and disease. Current research focuses on the gut–brain–fungal axis, exploring how fungal metabolites may influence mood, cognition, and neuroinflammation, and how fungal antigens interact with immune regulation in chronic conditions.
The mycobiome represents the fungal dimension of the human ecosystem. It is neither wholly beneficial nor harmful but instead participates in a delicate symbiosis with bacteria and the immune system. When this equilibrium is disturbed, fungi can shift from benign companions to inflammatory triggers. Understanding and supporting the mycobiome through diet, microbiome diversity, and immune balance is essential for holistic health.
References
- Huffnagle, G. B., & Noverr, M. C. (2013). The emerging world of the fungal microbiome. Trends in Microbiology, 21(7), 334–341.
- Iliev, I. D. & Leonardi, I. (2017). Fungal dysbiosis: Immunity and interactions at mucosal barriers. Nature Reviews Immunology, 17(9), 635–646.
- Iliev, I. D. et al. (2012). Interactions between commensal fungi and the gut immune system. Science, 336(6086), 1314–1318.
- Noverr, M. C. & Huffnagle, G. B. (2004). Does the microbiota regulate immune responses outside the gut? Trends in Microbiology, 12(12), 562–568.
- Zhang L, Zhan H, Xu W, Yan S, Ng SC. (2021). The role of gut mycobiome in health and diseases. Therapeutic Advances in Gastroenterology. 2021;14.
- Seed, P. C. (2014). The human mycobiome. Cold Spring Harbor Perspectives in Medicine, 4(3), a019810.
- Underhill, D. M., & Iliev, I. D. (2014). The mycobiota: Interactions between commensal fungi and the host immune system. Nature Reviews Immunology, 14(6), 405–416.